Skip to content
Recall Observatory FDA recall evidence

Drug product

Argatroban Injection 50 mg per 50ml (1 mg per ml) For Intravenous Infusion Only, a) Single Use Vial (NDC 42367-203-07), b) 10 Single Use Vials(NDC 42367-203-84), Rx Only, Manufactured by: Cipla LTD, India, Manufactured for: Eagle Pharmaceuticals, Inc. Woodcliff Lake, NJ 07677 USA, Marketed by: The Medicines Company, Parsippany, NJ 07054 USA

D-1429-2012

December 02, 2011

Class I

Product summary

Firm
Eagle Pharmaceuticals Inc.
Event
Event 61108
Status
Terminated
Classification
Class I
Quantity
19,660 vials
Official record key
drug-enforcement:D-1429-2012

Official wording

Reason: A complaint was received from a hospital pharmacy on 11/10/11 for crystalline particulates in a single vial from Lot V10194. Additional small visible particles consisting of fibers were identified.

Code information: Lot #V10189, Lot #V10191, Lot #V10194, Exp 01/13; Lot #V10223; Exp 02/13

Distribution pattern: New Jersey

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    particulates